← SynDRA
TOYOCAMYCIN
SynDRA canonical compound SYN0003844 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | ERN1 |
|---|
| Mechanism of action | serine/threonine kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- serine/threonine kinase inhibitor
Drug classes
- Antibiotics, Antineoplastic
- Antimetabolites, Antineoplastic
Cross-references
Synonyms
- Vengicide
- Uramycin B
- Antibiotic 1037
- Siromycin
- Cyanotubericidin
- Ahygroscopin-B
- 7-Deaza-7-cyanoadenosine
- Antibiotic E212
- Unamycin B
- Antibiotic A-399-Y4
- E-212
- Naritheracin
- NSC 63701
- A-399-Y4
- Toyokamycin
- L7995C4D7F
- CHEBI:134606
- NSC 99843
- Deazacyanoadenosine
- RefChem:190519
- DTXCID601516397
- E-212-1
- BRN 0048454
- toyocamicin
- UNII-L7995C4D7F
- Ara-toyocamycine
- TO1
- MFCD00866513
- Antibiotic 1037?
- Vengicide; Toyocamycin
- 3re4
- TOYOCAMYCIN [MI]
- 7-Cyano-7-deazaadenosine
- 4-26-00-01419 (Beilstein Handbook Reference)
- SCHEMBL336095
- cid_247955
- orb1307657
- SCHEMBL29363964
Look up TOYOCAMYCIN in the interactive SynDRA portal →